Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

More Peace Deals?

The Trump administration has been working to make even more…
Read more

COVID-19 Has More People Going Cashless

With public worrying about the COVID-19 virus, the use of…
Read more

What’s in the EU-UK Brexit Deal?

After long months of negotiations, the EU and UK have a Brexit…
Read more